Characterization of an early dendritic cell precursor derived from murine lineage-negative hematopoietic progenitor cells

• Published in: Experimental hematology Vol. 30; no. 5; pp. 430 - 439
• Main Authors: Jackson, Sharon H., Alicea, Candido, Owens, Jennie W., Eigsti, Calvin L., Malech, Harry L.
• Format: Journal Article
• Language: English
• Published: Netherlands Elsevier Inc 01.05.2002
• Subjects: Analysis of Variance; Animals; Cell Differentiation - drug effects; Cell Differentiation - physiology; Cell Division - drug effects; Cells, Cultured; Dendritic Cells - cytology; Granulocyte-Macrophage Colony-Stimulating Factor - pharmacology; Hematopoietic Stem Cells - cytology; Histocompatibility Antigens Class II - analysis; Interleukin-4 - pharmacology; Kinetics; Lymphocyte Culture Test, Mixed; Macrophage Colony-Stimulating Factor - pharmacology; Mice; Mice, Inbred C57BL; Mice, Knockout; Stem Cell Factor - pharmacology; Time Factors
• ISSN: 0301-472X; 1873-2399
• DOI: 10.1016/S0301-472X(02)00792-0

We define characteristics of a dendritic cell (DC) precursor generated from murine lineage-negative (Lin−) Sca1+ hematopoietic progenitor cells (HPC). Lin−Sca1+ HPC cultured 9 days in 100 ng/mL stem cell factor (SCF), 20 ng/mL interleukin-3 (IL-3), 50 ng/mL monocyte colony-stimulating factor (M-CSF), 5 ng/mL granulocyte-monocyte colony-stimulating factor (GM-CSF), and 25 ng/mL FLT3-ligand (FLT3-L) proliferate 387-fold and differentiate into DC precursors. Switch to ≥100 ng/mL GM-CSF + 1500 U/mL IL-4 or 500 U/mL tumor necrosis factor-α (TNF-α) for 3 days induces development into immature DC that are responsive to bacterial lipopolysaccharide (LPS)-induced maturation. Lin−Sca1+ HPC in the first 9 days of culture differentiate into DC precursors expressing surface CD11bbright, CD11cmod, CD86low-mod, major histocompatibility class II antigen (MHC) IIlow, DEC 205low, but are surface CD40− and contain high levels of intracellular MHC II. Unlike immature DC described by others, these DC precursors are refractory to maturation with LPS and minimally stimulate allogeneic T lymphocytes in mixed leukocyte reactions (MLR). Switch to high-dose GM-CSF alone with IL-4 or TNF-α differentiates these DC precursors into immature DC. LPS treatment of the immature DC results in mature DC that express surface CD40high and CD86high, secrete IL-1β and IL-12, and strongly stimulate MLR. These studies define a distinct DC precursor derived from murine HPC that precedes development of immature and mature DC.